Is HH Biotechnology Holdings stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, HH Biotechnology Holdings pays dividends. Last time was Friday 15th of July 2005 where the investors holding the stock on Wednesday 29th of June 2005 were paid $0.36 per share. Over the last 1 times between 2005 and 2005, HH Biotechnology Holdings has paid $0.36 with an average of $0.36 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for HH Biotechnology Holdings 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $0.600, you would have made a loss of $-0.600 per share or -99.98%
No, the average daily trading liquidity for HH Biotechnology Holdings is $203 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
HH Biotechnology Holdings has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.77, the company's ability to pay off the debt is good. HH Biotechnology Holdings has a very good net profit margin of 30.99% and should have very high tolerances against inflation.
We have calculated the inflation risk for HH Biotechnology Holdings to be low [0 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.